Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com
Customer area
ITEN

Family · Pharmaceutical analytical standards

Golimumab

A fully human monoclonal antibody that neutralises TNF-alpha, approved in 2009 in the United States and Europe for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, and later also for ulcerative colitis. This family brings together the active ingredient.

Did you know?Although it is a fully human antibody, it was born in mice: transgenic mice immunised with human TNF-alpha, from which the antibody-producing clone was selected.

Go to the active ingredient →
Structure not applicable: biological materialActive ingredientGolimumab BRPCat. No. P-G055-001CAS 476181-74-5

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Structure not applicable: biological materialBiological preparationGolimumab BRPEDQM code Y0002502Family Golimumab
Structure not applicable: biological materialReference substanceGolimumab CRSEDQM code Y0002346Family Golimumab

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.

See our servicesContact us